Section I. Introduction to diagnosis and laboratory techniques

 

1. Approaches to Classification of Lymphoma and Leukemia

Dan Jones, MD, PhD

2. Immunohistochemical Profiling of Lymphoma

Matthew Anderson, MD, PhD, Yasodha Natkunam, MD, PhD

3. Flow Cytometry in the Evaluation of Hematologic Malignancies

Jeffrey L Jorgensen, MD, PhD

4. Molecular Diagnostics and Cytogenetic Testing

Su Chen, MD, PhD, Zhuang Zuo, MD, PhD, Dan Jones, MD

 

 Section II. Neoplasms of the Bone Marrow

 

5. The Bone Marrow in Normal and Diseased States

Dan Jones, MD, PhD, Roberto N Miranda, MD

6. Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms

Sa A Wang, MD

7. Acute Myeloid Leukemia

Carlos E Bueso-Ramos, MD, PhD

8. Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Farhad Ravandi, MD

9. Myeloproliferative Neoplasms

C. Cameron Yin, MD, PhD, Dan Jones, MD, PhD

10. Chronic Myelogenous Leukemia

Robert P Hasserjian, MD

11. Treatment of Myeloproliferative Neoplasms

Starla Sweany, PharmD, BCOP, Elias Jabbour, MD

 

Section III. Tumors of the Lymph Node and Extranodal Tissues

 

12. Lymph Node Biology and Lymphadenitis

Roberto N Miranda, MD

13. Lymphoblastic Leukemia and Lymphoma

Andrea M Sheehan, MD

14. Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Ellen Schlette, MD

15. Marginal Zone Lymphomas

Rachel L Sargent, MD

16. Follicular Lymphoma and Mantle Cell Lymphoma

Dan Jones, MD

17. Aggressive B-Cell Lymphomas: Large B-Cell Lymphoma and Burkitt Lymphoma

Henry Y Dong, MD, PhD

18. Therapy of B-Cell Lymphoproliferative Disorders

Nathan Fowler, MD, Sandra Horowitz, PharmD, Peter McLaughlin, MD

19. Plasma Cell Myeloma and Other Plasma Cell Dyscrasias

Marwan A Yared, MD

20. Hodgkin Lymphoma

Robert Lin, MD, Dan Jones, MD, PhD, Sherif Ibrahim, MD, PhD

21. Treatment of Hodgkin Lymphoma

Luis E Fayad, MD, Samer A Srour, MB, ChB

 

22. Classification of T-Cell and NK-Cell Malignances

Dan Jones, MD, PhD

23. Treatment of Non-Cutaneous T-Cell and NK-Cell Malignancies

Marco Herling, MD

24. Cutaneous T-Cell Lymphoma

Pranil Chandra, DO, Mauricio P Oyarzo, MD, Dan Jones, MD, PhD

25. Treatment of Cutaneous T-Cell Lymphomas

Katherine M Cox, MD, Madeleine Duvic, MD

26. Histiocytic and Dendritic Cell Neoplasms

Kedar V Inamdar, MD, PhD, Dan Jones, MD, PhD

27. Extranodal Lymphomas and Tumors of the Thymus

Brian D Stewart, MD, John T Manning, MD, Dan Jones, MD

 

Section IV. Stem Cell Transplantation

 

28. Clinical Aspects of Hematopoietic Stem Cell Transplantation

Elizabeth J Shpall, MD, Marcos de Lima, MD

29. Post-Transplant Molecular Monitoring

Dan Jones, MD, PhD

30. Post-Transplant Immune Function and the Development of Lymphoma

Dequin Ma, MD, PhD and Dan Jones, MD, PhD

 

Section V. Experimental Hematopathology

 

31. Hematopoiesis and Stem Cell Biology

Claudiu Cotta, MD, PhD

32. Role of Host Genetics in Lymphoma

Ahmet Dogan, MD, PhD

33. Developing Prognostic Models for Diffuse Large B-Cell Lymphoma
Izidore S Lossos, MD

34. Growth Signaling and Survival Pathways in Aggressive B-Cell Lymphoma

Lan V Pham, PhD, Richard J Ford, MD, PhD

35. Proteomic Profiling and Target Identification in Lymphoma

Megan S Lim, MD, PhD

36. Mouse Models of Lymphoma and Lymphoid Leukemia

M James You, MD, PhD

37. Mouse Models of Myeloid Leukemia

Robert B Lorsbach, MD, PhD

38. Designing Targeted Therapies for Lymphomas and Leukemias

Dan Jones, MD, PhD

Study Guide